Literature DB >> 7118991

Usefulness of the PAL test in the diagnosis of lung cancer.

E Kłosińska-Kita, E Wiatr, B Rykiel, E Rowińska, W Roszkowski.   

Abstract

Usefulness of a simple microagglutination test for diagnosis of malignant diseases was evaluated in the diagnosis of lung cancer. The test was not specific, being positive in 82% of malignant and 55% of nonmalignant cases. It was shown that poly-L-lysine-induced agglutination of lymphocytes reflects rather changed serum than cell properties and cannot be taken as a method for detection of sensitized cells.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7118991     DOI： 10.1007/bf00409704

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  8 in total

1.  Electrophoretic mobility of blood lymphocytes in cancer patients.

Authors:  R Plagne; P Chollet; D Guerin; J Chassagne; J M Bidet; B Sauvezie
Journal:  Biomedicine       Date:  1975-12-20

2.  Histones and cancer test.

Authors:  E W Johns; J A Pritchard; J L Moore; W H Sutherland; C A Joslin; J A Forrester; A J Davies; A M Neville; R G Fish
Journal:  Nature       Date:  1973-09-14       Impact factor: 49.962

3.  Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque.

Authors:  D English; B R Andersen
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

4.  Lymphocyte sensitisation: an in-vitro test for cancer?

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

5.  Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity.

Authors:  A M Baskies; P B Chretien; J F Weiss; R W Makuch; R A Beveridge; W J Catalona; H E Spiegel
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

6.  Agglutination of peripheral blood lymphocytes from cancer patients and not from healthy controls, with the F2A1 histone fraction.

Authors:  D Sabolović; N Sabolović; A Moutte; S Leibovici; B Sauvezie; P Chollet; R Plagne
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

7.  The PAL test for malignant disease in man.

Authors:  W A Schottler; H W Bauer
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

8.  Detection of sensitized human blood lymphocytes by agglutination with basic peptides: a possible test for malignant disease.

Authors:  H W Bauer; W Ax
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.